Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells
go back to main search page
Accession:CMO:0001421 term browser browse the term
Definition:A calculated value in which the number of proliferating cell nuclear antigen-positive cells is divided by the total number of liver tumorous lesion cells and presented as a ratio, fraction, quotient or percentage.
Synonyms:related_synonym: PCNA index;   ratio of PCNA-positive cells to total liver tumorous lesion cells;   ratio of proliferating cell nuclear antigen-positive nuclei to total liver tumorous lesion nuclei



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          liver tumorous lesion measurement 29
            calculated liver tumorous lesion measurement 8
              ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells 0
paths to the root